These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes. Benn DE; Richardson AL; Marsh DJ; Robinson BG Ann N Y Acad Sci; 2006 Aug; 1073():104-11. PubMed ID: 17102077 [TBL] [Abstract][Full Text] [Related]
32. Germinal defects of SDHx genes in patients with isolated pituitary adenoma. Mougel G; Lagarde A; Albarel F; Essamet W; Luigi P; Mouly C; Vialon M; Cuny T; Castinetti F; Saveanu A; Brue T; Barlier A; Romanet P Eur J Endocrinol; 2020 Oct; 183(4):369-379. PubMed ID: 32621582 [TBL] [Abstract][Full Text] [Related]
33. Mutational profile and genotype/phenotype correlation of non-familial pheochromocytoma and paraganglioma. Albattal S; Alswailem M; Moria Y; Al-Hindi H; Dasouki M; Abouelhoda M; Alkhail HA; Alsuhaibani E; Alzahrani AS Oncotarget; 2019 Oct; 10(57):5919-5931. PubMed ID: 31666924 [TBL] [Abstract][Full Text] [Related]
34. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes. Gimenez-Roqueplo AP; Dahia PL; Robledo M Horm Metab Res; 2012 May; 44(5):328-33. PubMed ID: 22328163 [TBL] [Abstract][Full Text] [Related]
35. Germline genetic variants in pheochromocytoma/paraganglioma: single-center experience. Lima JV; Scalissi NM; de Oliveira KC; Lindsey SC; Olivati C; Ferreira EN; Kater CE Endocr Oncol; 2023 Jan; 3(1):e220091. PubMed ID: 37529773 [TBL] [Abstract][Full Text] [Related]
36. Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea. Kim JH; Seong MW; Lee KE; Choi HJ; Ku EJ; Bae JH; Park SS; Choi SH; Kim SW; Shin C; Kim SY Clin Genet; 2014 Nov; 86(5):482-6. PubMed ID: 24134185 [TBL] [Abstract][Full Text] [Related]
37. Tumour detection and outcomes of surveillance screening in SDHB and SDHD pathogenic variant carriers. White G; Velusamy A; Anandappa S; Masucci M; Breen LA; Joshi M; McGowan B; Hubbard JGH; Obholzer R; Christodoulou D; Jacques A; Touska P; Hassan FU; Izatt L; Carroll PV Endocr Connect; 2022 Feb; 11(2):. PubMed ID: 35060925 [TBL] [Abstract][Full Text] [Related]
38. Cost-minimization analysis of sequential genetic testing versus targeted next-generation sequencing gene panels in patients with pheochromocytoma and paraganglioma. Pipitprapat W; Pattanaprateep O; Iemwimangsa N; Sensorn I; Panthan B; Jiaranai P; Chantratita W; Sorapipatcharoen K; Poomthavorn P; Mahachoklertwattana P; Sura T; Tunteeratum A; Srichan K; Sriphrapradang C Ann Med; 2021 Dec; 53(1):1244-1256. PubMed ID: 34309460 [TBL] [Abstract][Full Text] [Related]
39. Germline mutations of the TMEM127 gene in patients with paraganglioma of head and neck and extraadrenal abdominal sites. Neumann HP; Sullivan M; Winter A; Malinoc A; Hoffmann MM; Boedeker CC; Bertz H; Walz MK; Moeller LC; Schmid KW; Eng C J Clin Endocrinol Metab; 2011 Aug; 96(8):E1279-82. PubMed ID: 21613359 [TBL] [Abstract][Full Text] [Related]
40. Characteristics and genetic testing outcomes of patients with clinically suspected paraganglioma/pheochromocytoma (PGL/PCC) syndrome in Singapore. Ting KR; Ong PY; Wei SOG; Parameswaran R; Khoo CM; Deepak DS; Lee SC Hered Cancer Clin Pract; 2020 Dec; 18(1):24. PubMed ID: 33308260 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]